Ovarian cancer (OC) remains a clinical challenge for its difficulty in early diagnosis and insensitivity to treatments. Gut microbiota modulates multiple carcinoma progression through immunoregulation
Ovarian cancer (OC) remains a clinical challenge for its difficulty in early diagnosis and insensitivity to treatments. Gut microbiota modulates multiple carcinoma progression through immunoregulation
we collected fecal samples from 382 female patients from Zhejiang Cancer Hospital in China, including 239 patients with OTs (148 patients with OC and 91 with BOTs), 90 patients with OBTs, and 53 with